Virtus ETF Advisers’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-26,021
| Closed | -$229K | – | 532 |
|
|
2019
Q3 | $229K | Sell |
26,021
-1,449
| -5% | -$12.8K | 0.05% | 223 |
|
|
2019
Q2 | $254K | Buy |
+27,470
| New | +$254K | 0.05% | 271 |
|
|
2019
Q1 | – | Sell |
-23,806
| Closed | -$224K | – | 309 |
|
|
2018
Q4 | $224K | Buy |
23,806
+8,545
| +56% | +$80.4K | 0.04% | 173 |
|
|
2018
Q3 | $307K | Sell |
15,261
-10,919
| -42% | -$220K | 0.03% | 185 |
|
|
2018
Q2 | $764K | Sell |
26,180
-4,993
| -16% | -$146K | 0.68% | 59 |
|
|
2018
Q1 | $928K | Buy |
31,173
+16,779
| +117% | +$500K | 0.81% | 54 |
|
|
2017
Q4 | $463K | Buy |
14,394
+2,549
| +22% | +$82K | 0.58% | 44 |
|
|
2017
Q3 | $412K | Buy |
11,845
+1,084
| +10% | +$37.7K | 0.06% | 105 |
|
|
2017
Q2 | $320K | Sell |
10,761
-5,087
| -32% | -$151K | 0.05% | 109 |
|
|
2017
Q1 | $473K | Buy |
15,848
+1,519
| +11% | +$45.3K | 0.08% | 104 |
|
|
2016
Q4 | $251K | Buy |
14,329
+38
| +0.3% | +$666 | 0.08% | 141 |
|
|
2016
Q3 | $340K | Hold |
14,291
| – | – | 0.16% | 88 |
|
|
2016
Q2 | $229K | Buy |
14,291
+4,646
| +48% | +$74.4K | 0.17% | 116 |
|
|
2016
Q1 | $202K | Sell |
9,645
-605
| -6% | -$12.7K | 0.28% | 81 |
|
|
2015
Q4 | $277K | Buy |
+10,250
| New | +$277K | 0.76% | 45 |
|